BUSINESS Aurobindo Pharma’s CuraTeQ Biologics receives Health Canada nod for Bevqolva biosimilar May 1, 2026
BUSINESS Aurobindo Pharma’s CuraTeQ Biologics announces positive results for omalizumab biosimilar study Apr 6, 2026
BUSINESS Aurobindo Pharma subsidiary CuraTeQ Biologics enters EU biosimilars agreement with STADA Mar 25, 2026